Blog: Sarcoma

Randomised Controlled Trial: Improvements in side effects of metastatic sarcoma patients (ASCO 2025)

SARC-Digital is a Randomised Controlled Trial (RCT) focusing on our personalised patient support solution, specifically for patients with advanced or metastatic sarcoma. The trial’s interim results were shared with the scientific community at the annual meeting of the American Society for Clinical Oncology (ASCO) through an abstract highlighting its findings.